Core Viewpoint - The company, Awei Technology Co., Ltd., has been awarded the Second Prize of the Hubei Provincial Science and Technology Progress Award for its project on "Key Technological Innovations and Clinical Applications of Molecular Diagnosis of Acute Leukemia" [1][2]. Group 1: Project Details - The awarded project addresses four major clinical challenges in acute leukemia: early identification difficulties, narrow treatment windows, delayed classification, and high dependence on continuous monitoring [1]. - The project has developed an integrated diagnostic technology system that includes molecular mechanisms, sampling tools, diagnostic platforms, and clinical applications [1]. - Key innovations include the revelation of the "ROS-JAB1-TRX" pathway driving malignant proliferation of leukemia stem cells, and the development of a painless puncture needle and preservation liquid system to overcome challenges in sample collection [1]. Group 2: Impact on the Company - The award is a recognition of the company's technological innovation and research capabilities, which is expected to enhance its core competitiveness [2]. - The company plans to increase its research efforts to further improve its technological innovation capabilities [2]. - While the award is anticipated to have a positive impact on the company's future development, it is noted that there will be no significant immediate effect on the company's financial performance [2].